What Does Research Suggest About Unexplained Infertility and Egg Quality?
September 3, 2025
September 3, 2025

For many couples in Nagpur, the fertility journey starts later than it should, not because they were unaware that something was wrong, but because the infrastructure for addressing it was not easily within reach. Reproductive gynaecology in central India has expanded, but specialist care in reproductive immunology remains limited, and the gap between experiencing a problem and finding the right clinical framework for it can stretch into years.
ICPRM was built for exactly this kind of case. The centre specialises in reproductive immunology, with a focus on couples who have had multiple pregnancy losses, unexplained infertility, or repeated IVF failure without a clear explanation. Because the consultation process begins online, Nagpur-based couples do not need to travel to access an initial clinical review. The best infertility doctors in Nagpur at ICPRM bridge that gap with a structured remote-first approach that brings specialist-level evaluation to patients wherever they are.
Reproductive tract infections are a clinically underappreciated cause of infertility, particularly in central Indian cities where gynaecological care is sought late or treated incompletely. Conditions such as chronic endometritis, subclinical pelvic inflammatory disease, and persistent cervical infection can cause structural changes over time, including subtle tubal damage and altered endometrial architecture. But beyond the structural, these infections also leave an immune footprint. The uterine immune environment can remain in a heightened inflammatory state long after the active infection has resolved, making it hostile to implantation.
This combination of delayed care and immune consequence means that many women in Nagpur who present with infertility are dealing with layers of causation that need to be separated and addressed individually. What appears to be unexplained infertility may, under proper immune investigation, reveal a pattern of immune dysregulation rooted in a history of reproductive infection that was treated adequately from an infectious standpoint but not from an immunological one.
The endometrium is not a passive surface. It is an immunologically active tissue, populated by a complex community of immune cells, including natural killer cells, macrophages, and T regulatory cells, that collectively determine whether a pregnancy will be sustained. When this community is disrupted, whether by infection history, systemic inflammation, or a failure of immune tolerance toward the embryo, implantation becomes unreliable. A uterus can appear structurally intact on ultrasound while its immune microenvironment is consistently working against successful pregnancy.
Lymphocyte immunotherapy, the foundation of ICPRM's ImmuLIT® treatment, intervenes at this level. Research in reproductive immunology literature consistently demonstrates that for patients with immune-mediated implantation failure and recurrent pregnancy loss, this therapy produces meaningful improvements in pregnancy continuation rates. The mechanism is targeted and the clinical evidence is established.
Dr. Mugdha Raut and Dr. Mohan Rautat ICPRM, both Consultant Gynaecologists and Clinical Reproductive Immunologists, begin each fertility evaluation by understanding what previous treatments may have overlooked at the immune level. Being the trusted infertility experts in Nagpur, they build an immune investigation plan that is tailored to that specific reproductive history. This is not a standard panel applied uniformly. It is a targeted workup designed to identify whether the reproductive immune environment is the reason pregnancies have not continued.
Where immune dysfunction is confirmed, ImmuLIT® is offered as the primary intervention. The procedure is structured to be accessible: a single outpatient sitting of approximately three hours, no hospitalisation, and a follow-up protocol that can be largely managed remotely. For couples who have waited a long time for a coherent clinical answer, the directness of this approach is itself a meaningful change from the pattern of inconclusive testing and empirical treatment they may have experienced before.
The treatment pathway is designed to be thorough without being complicated, and accessible without compromising clinical rigour.
Nagpur couples who reach ICPRM often come after consulting multiple gynaecologists, fertility clinics, and sometimes even undergoing IVF without ever receiving an immune evaluation. Since the local fertility ecosystem has limited access to reproductive immunology-focused care, our online-first process has become valuable for many patients in the region.
And for those who wish to visit us, our centre is located at Cardion Hospital, Opposite Dinanath High School, Tikekar Road, Dhantoli, Nagpur - 440012. Consultations and investigations can begin remotely, while the ImmuLIT® procedure is performed at ICPRM’s centre once patients are confirmed as suitable candidates.
What the leading fertility specialists in Nagpur at ICPRM provide for Nagpur patients is diagnostic closure. Couples who have carried a question about why their pregnancies keep failing, sometimes for years, receive a specific and medically grounded answer through the immune evaluation. When that answer points to an addressable mechanism, the next step becomes clear rather than speculative, and the emotional shift that comes with that clarity is something the treatment timeline alone cannot produce.
1. Can a gynaecological infection from years ago still be affecting my fertility now?
Yes. The immune changes triggered by a reproductive tract infection can persist well beyond the resolution of the infection itself. Chronic low-grade inflammation in the uterine environment is one of the mechanisms through which past infections translate into current implantation difficulties.
2. All my standard fertility tests are normal. Is it worth getting an immune evaluation?
Normal standard tests are one of the clearest indications for an immune evaluation. Reproductive immunology investigations examine a layer of fertility biology that standard panels do not reach. If you have had recurrent miscarriages or repeated implantation failure with normal reports, immune factors are a logical next area to investigate.
3. Is there a reproductive immunology specialist available in Nagpur?
Reproductive immunology as a specialised field is not widely available in central India. ICPRM's consultation process begins online, allowing Nagpur-based patients to access specialist-level immune evaluation without requiring an in-person visit for the initial review.
4. How many pregnancy losses qualify someone for immune evaluation at ICPRM?
Most reproductive medicine guidelines suggest investigation after two consecutive losses. However, if there is an additional clinical pattern, such as a history of infections or losses consistently at the same gestational stage, an evaluation may be appropriate after a single loss in some cases.
5. What makes ImmuLIT different from standard treatment for recurrent miscarriage?
Standard treatment for recurrent miscarriage often involves empirical interventions such as progesterone supplementation or low-dose aspirin, applied without a confirmed immune diagnosis. ImmuLIT is a specific immune intervention based on a confirmed immune mechanism identified through prior investigation.
6. Does the investigation at ICPRM require me to travel, or can it be done in Nagpur?
The investigation panel recommended by ICPRM can often be completed at a diagnostics facility near you. ICPRM will specify the tests needed and advise on where they can be conducted. The results are then reviewed remotely before any decision about the ImmuLIT procedure is made.
7. What if ICPRM's investigation does not find an immune cause?
If the immune evaluation does not identify a mechanism, ICPRM will communicate this clearly and guide you toward other relevant investigations or specialists based on your complete history. Not every case of recurrent pregnancy failure has an immune basis, and identifying that is itself a clinically useful outcome.

M.D.D.G.O, FCRI
Consultant Gynaecologist & Obstetrician
Clinical Reproductive Immunologist

M.D., D.G.O., F.C.R.I.(ASRI)
Consultant Gynaecologist & Obstetrician
Clinical Reproductive Immunologist